Amy Rommel

843 total citations · 1 hit paper
7 papers, 559 citations indexed

About

Amy Rommel is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Amy Rommel has authored 7 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Amy Rommel's work include DNA Repair Mechanisms (2 papers), Glioma Diagnosis and Treatment (2 papers) and Epigenetics and DNA Methylation (2 papers). Amy Rommel is often cited by papers focused on DNA Repair Mechanisms (2 papers), Glioma Diagnosis and Treatment (2 papers) and Epigenetics and DNA Methylation (2 papers). Amy Rommel collaborates with scholars based in United States, Canada and Switzerland. Amy Rommel's co-authors include Inder M. Verma, Alan Saghatelian, Maksim V. Plikus, Xiaojie Wang, Francesca Puca, Satchidananda Panda, Matthew J. Kolar, Gabriele Sulli, Yasushi Soda and Chad Myskiw and has published in prestigious journals such as Nature, Nucleic Acids Research and Clinical Cancer Research.

In The Last Decade

Amy Rommel

7 papers receiving 548 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence

2018 288 citations Gabriele Sulli, Amy Rommel et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Rommel United States	6	257	192	109	85	83	7	559
Adarsh Shankar United States	16	307 1.2×	160 0.8×	54 0.5×	174 2.0×	123 1.5×	24	761
Rute Loureiro Portugal	10	284 1.1×	41 0.2×	62 0.6×	82 1.0×	63 0.8×	12	464
Chi‐Wing Chow United States	11	226 0.9×	114 0.6×	108 1.0×	45 0.5×	109 1.3×	12	505
Naval P. Shanware United States	10	502 2.0×	57 0.3×	63 0.6×	181 2.1×	85 1.0×	10	774
Ann MacLaren United Kingdom	10	571 2.2×	42 0.2×	126 1.2×	74 0.9×	183 2.2×	23	840
Pablo Lorenzano Menna Argentina	10	341 1.3×	35 0.2×	80 0.7×	59 0.7×	84 1.0×	21	501
Andrea Loreto United Kingdom	16	373 1.5×	26 0.1×	108 1.0×	17 0.2×	98 1.2×	36	902
Natacha Moulharat France	10	313 1.2×	54 0.3×	43 0.4×	31 0.4×	25 0.3×	11	444
Laurence Bresson‐Bepoldin France	13	182 0.7×	42 0.2×	27 0.2×	32 0.4×	29 0.3×	21	368
Annakaisa M. Herrala Finland	14	309 1.2×	27 0.1×	84 0.8×	60 0.7×	78 0.9×	22	706

Countries citing papers authored by Amy Rommel

Since Specialization

Citations

This map shows the geographic impact of Amy Rommel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Rommel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Rommel more than expected).

Fields of papers citing papers by Amy Rommel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Rommel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Rommel. The network helps show where Amy Rommel may publish in the future.

Co-authorship network of co-authors of Amy Rommel

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Rommel. A scholar is included among the top collaborators of Amy Rommel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Rommel. Amy Rommel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Motea, Edward A., Farjana Fattah, Ling Xiao, et al.. (2018). Kub5-Hera RPRD1B Deficiency Promotes “BRCAness” and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers. Clinical Cancer Research. 24(24). 6459–6470. 12 indexed citations

2.

Sulli, Gabriele, Amy Rommel, Xiaojie Wang, et al.. (2018). Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence. Nature. 553(7688). 351–355. 288 indexed citations breakdown →

3.

Thanasupawat, Thatchawan, Suchitra Natarajan, Amy Rommel, et al.. (2017). Dovitinib enhances temozolomide efficacy in glioblastoma cells. Molecular Oncology. 11(8). 1078–1098. 25 indexed citations

4.

Natarajan, Suchitra, Thatchawan Thanasupawat, Amy Rommel, et al.. (2014). Targeting oncofetal high mobility group A2 (HMGA2) to increase sensitivity to temozolomide (TMZ) in glioblastoma (GB) cells. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 41(s2). S3–S4. 2 indexed citations

5.

Morales, Julio C., P. Richard, Amy Rommel, et al.. (2014). Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair. Nucleic Acids Research. 42(8). 4996–5006. 38 indexed citations

6.

Bey, Erik A., Kathryn E. Reinicke, Melissa C. Srougi, et al.. (2013). Catalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers. Molecular Cancer Therapeutics. 12(10). 2110–2120. 84 indexed citations

7.

Soda, Yasushi, Chad Myskiw, Amy Rommel, & Inder M. Verma. (2013). Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. Journal of Molecular Medicine. 91(4). 439–448. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact